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Abstract
Between June 9–11, 2019, the International Conference on Intelligent Biology and Medicine (ICIBM 2019) was held
in Columbus, Ohio, USA. The conference included 12 scientific sessions, five tutorials or workshops, one poster
session, four keynote talks and four eminent scholar talks that covered a wide range of topics in bioinformatics,
medical informatics, systems biology and intelligent computing. Here, we describe 13 high quality research articles
selected for publishing in BMC Bioinformatics.
Introduction
The 2019 International Conference on Intelligent Biology
and Medicine (ICIBM 2019) provided a multidisciplinary
forum for computational scientists and experimental
biologists to share their most recent findings in the field
of cancer genomics, systems biology, medical informatics,
big data analytics and machine learning, among others.
The conference was held on June 9–11, 2019, in Colum-
bus, Ohio, USA. Approximately 200 researchers and
students across the world attended the meeting. In this
special issue, we have collected 13 original research
articles reflecting the cutting-edge researches in bioinfor-
matics. As the advance of all kinds of omics studies, bio-
informatics has become the indispensable powerhouse
behinds all analyses. This is reflected in our selection, as
these papers cover traditional areas in genomics, tran-
scriptomics, proteomics, as well as new research foci such
as drug discovery, metabolomics, and ribosome sequen-
cing analysis. We also observe a shift of research interest
from developing tools for analyzing high-throughput data
towards translational applications, as reflected in several
papers that focus on bioinformatics analysis of large-scale
data sets to test biological hypothesis regarding disease
mechanisms. In the following, we briefly summarize the
13 selected papers.
The science program for the ICIBM 2019
bioinformatics track
In the first paper by Ayed et al. [1] the authors devel-
oped a novel chemical representation method: Latent
Target Interaction Profile (LTIP). Traditionally, chemical
fingerprints represent a widely used feature to build ma-
chine learning models to predict response upon the
chemical perturbation on a biological system in the field
of computational drug discovery. However, chemical fin-
gerprints that are derived from chemical structures ig-
nore the biological context; thus, they suffer from
several problems such as the activity cliff and curse of
dimensionality. In comparison, LTIP embeds chemicals
into a low dimensional continuous latent space that rep-
resents genome-scale chemical-target interactions, so
that it can be used as a feature to build machine learning
models. To evaluate this approach, the authors used
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drug sensitivity of cancer cell lines as a benchmark, and
demonstrated that the LTIP robustly outperforms chem-
ical fingerprints regardless of machine learning algo-
rithms. Importantly, LTIP may also play complementary
role with the chemical fingerprints, so that it can be
combined with other fingerprints to further improve the
performance of bioactivity prediction. The authors con-
cluded that LTIP in particular and multi-scale modeling
in general has a strong potential in predictive modeling
of chemical modulation of biological activities.
In the next paper by Feng et al. [2] the authors devel-
oped MIRIA, a webserver for statistical, visual and meta-
analysis of RNA editing data in mammals. RNA editing
is defined as a critical post-transcriptional regulatory
RNA-processing event (excluding RNA splicing) that
generates an RNA transcript with a primary nucleotide
sequence different from its gene. In mammals, the most
common form of RNA editing is A-to-I RNA editing,
and this process leads to an A-to-G reading of the
cDNA molecule. To facilitate the identification of RNA
editing sites as well as downstream analysis, the authors
developed MIRIA as a user-friendly webserver that inte-
grates statistics and visualization techniques to facilitate
the comprehensive analysis of RNA editing site data
identified by the analysis pipelines and software pack-
ages. MIRIA is unique in that it provides several analyt-
ical functions, including RNA editing type statistics,
genomic feature annotations, editing level statistics,
genome-wide distribution of RNA editing sites, tissue-
specific analysis and conservation analysis. To demon-
strate the effectiveness of the method, they collected
high-throughput RNA sequencing (RNA-seq) data from
eight tissues across seven species as the experimental
data for MIRIA and constructed an example result page.
In summary, MIRIA provides both visualization and
analysis of mammal RNA editing data for experimental
biologists who are interested in revealing the functions
of RNA editing sites.
The next paper by Zhang et al. [3] describes M3S
(Multi-Modal Model Selection), a comprehensive model
selection for multi-modal single-cell RNA sequencing
data. M3S is an R package for gene-wise selection of the
most proper multi-modality statistical model and down-
stream analysis, useful in a single-cell or large-scale bulk
tissue transcriptomic data. Several unique features of
M3S are summarized here. First, it performs gene-wise
selection of the most parsimonious model among 11
most commonly utilized ones that can best fit the ex-
pression distribution of the gene. Second, it carries out
parameter estimation of a selected model. Third, it per-
forms differential gene expression test based on multi-
modality model. They benchmarked the M3S package
on simulated data sets and four real single cell RNA-seq
data sets, and showed that M3S has high specificity and
can effectively identify the outlier features. Furthermore,
they applied the M3S.test function to identify differen-
tially expressed genes associated with pre-defined sample
classes in the T cell scRNA-seq data set, and showed its
effectiveness by comparing to other commonly used dif-
ferential gene expression analysis methods for scRNA-
seq. In summary, the M3S package may facilitate the
downstream analysis of single-cell or large-scale bulk tis-
sue transcriptomic data.
The next paper by Cui et al. [4] described a method
called DeepShape for estimating isoform-level ribosome
abundance and distribution with ribosome sequencing
(ribo-seq) data. Ribo-seq is an important approach to
obtain ribosome distributions by sequencing “ribosome-
protected fragments” (RPFs). Computational analysis in-
volves mapping sequencing reads into transcripts and
obtaining the distributions of ribosomes along the whole
transcriptome. Existing methods either discard the mul-
tiple mapped-reads, allocate them randomly, or assign
them proportionally according to transcript abundance es-
timated from RNA-seq data. In comparison, DeepShape is
an RNA-seq free computational method to estimate ribo-
some abundance of isoforms, and it simultaneously com-
putes their ribosome profiles using a deep learning model.
Simulation studies and real data analysis demonstrated
that DeepShape can provide more accurate estimations on
both ribosome abundance and profiles when compared to
state-of-the-art methods. Therefore, DeepShape can serve
as a powerful tool for Ribo-seq data analysis.
The next paper by Wu et al. [5] presents SigUNet for
signal peptide recognition based on semantic segmenta-
tion. Proteins with signal peptides can enter the secretory
pathway and then be transported to appropriate organelles
where the proteins are able to conduct their functions.
Signal peptides work as a permission gateway that trans-
port proteins into endoplasmic reticulum. Recognition of
signal peptides is an important first step to understand the
active locations and functions of proteins. Many computa-
tional methods including deep learning methods have
been proposed to help signal peptide recognition. How-
ever, most of existing neural network models for signal
peptide recognition are relatively simple without lever-
aging the developments of other fields. This work pro-
poses a convolutional neural network architecture without
fully connected layers, which is an important architecture
improvement in computer vision. The experiments results
showed that the proposed model outperforms conven-
tional neural networks on eukaryotic signal peptides, but
the advantage is not observed on bacterial signal peptides
because of the small data size. In summary, this study de-
veloped an accurate signal peptide recognizer, demon-
strated the potential of leveraging advanced networks
from other fields, and made important modifications while
using advanced networks on signal peptide recognition.
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The next paper by Liu et al. [6] described a unified
short tandem repeats (STRs) profiling system across
multiple species with whole genome sequencing data.
STRs, also referred to as simple sequence repeats (SSRs)
or microsatellite loci, are DNA fragments made up of
tandem repeats of 1–6 bp sequence units. STRs are ubi-
quitous in eukaryotic genomes and are highly poly-
morphic. A variety of STRs profiling systems have been
developed for species including human, dog, cat, cattle, etc.
To maintain these systems simultaneously can be costly.
These mammals share many high similar regions along
their genomes, so it is possible to develop a unified STR
profiling system. In this study, the authors proposed and
developed a unified set of STR loci that could be simultan-
eously applied to multiple species. They presented an algo-
rithm which selected a subset of loci by incorporating the
optimized combined power of discrimination. Their results
showed that the unified set of loci have high combined
power of discrimination for both individual species and the
mixed population, indicating that the identified set of STR
loci could be applied to multiple species. In summary,
through bioinformatics analysis of whole-genome sequen-
cing data, the newly developed unified STR profiling system
can be applied to the individual identification or paternal
test of each of the ten common species: Sus scrofa (pig),
Bostaurus (cattle), Capra hircus (goat), Equus caballus
(horse), Canis lupus familiaris (dog), Felis catus (cat), Ovis
aries (sheep), Oryctolagus cuniculus (rabbit), Bos grunniens
(yak), and Homo sapiens (human).
The next paper by Abrams et al. [7] described a bio-
informatics protocol to evaluate RNA sequencing
normalization methods. For RNA-Seq data analysis,
normalization methods are typically used for reducing
the non-biologically derived variability inherent in
transcriptomic measurements. However, the compara-
tive efficacy of the various normalization techniques
has not been tested in a standardized manner. In the
study, the authors proposed tests that evaluate several
normalization techniques on a large-scale standard
data set. They concluded that transcripts per million
(TPM) was the best performing normalization method
based on its preservation of biological signal as compared
to the other methods tested. With the proposed bioinfor-
matics schema presented in the paper, researchers can
evaluate their own or future normalization methods to
further improve the field of RNA-Seq data analysis.
The next paper by Yu et al. [8] proposed a fully mod-
erated t-statistic in linear modeling of mixed effects for
differential expression analysis. Typical gene expression
profiling experiments with few replicates lead to great
variability in the estimates of gene variances, and several
moderated t-test methods based on linear models with
mixed effects have been developed to reduce this vari-
ability and to increase power of tests of differential
expression. However, they are inadequate for designs
with complex correlation structures, therefore applica-
tion of moderation methods to linear models with mixed
effects are needed for differential expression analysis. In
the study, the authors implemented a fully moderated t-
statistic method for linear models with mixed effects,
where both residual variances and variance estimates of
random effects are smoothed under a hierarchical Bayes
framework. They showed that the proposed method
can control the expected number of false positives at
the nominal level, while two other currently used
moderation methods fail. In summary, the proposed
method is able to improve power by moderation and
control the expected number of false positives prop-
erly at the nominal level.
The next paper by Klein et al. [9] performed bioinfor-
matics analysis to study the association between amyo-
trophic lateral sclerosis (ALS) and retroviruses. ALS is a
progressive neurodegenerative disorder affecting motor
neurons of the brain and spinal cord. To date, approxi-
mately 10–15% of ALS cases have been found to have a
genetic basis, and causal mutations have been identified
in ~ 70% of familial cases and ~ 10% of sporadic cases.
Emerging evidence suggests retroviruses play a role in
the pathophysiology of ALS. Specifically, activation of
ancient viral genes embedded in the human genome is
theorized to lead to motor neuron degeneration. To test
this hypothesis, the authors explored whether connections
exist between ALS and retroviruses through protein inter-
action networks (PIN) and pathway analysis, and consider
the potential roles in drug target discovery. Topological
and statistical analysis of the ALS-PIN and retrovirus-PIN
identified a shared, essential protein network and a core
cluster with significant connections with both networks.
Pathway enrichment analysis showed that this core cluster
is associated with the glucocorticoid receptor singling and
neuroinflammation signaling pathways. The same meth-
odology was applied to the West Nile and Polio virus,
which demonstrated trivial connectivity with ALS, sup-
porting the unique connection between ALS and retrovi-
ruses. In summary, bioinformatics analysis provides
evidence to support pathological links between ALS and
retroviral activation, and suggested the important roles of
the neuroinflammation and apoptotic regulation path-
ways. The continuation and further analysis of large-scale
genome studies may prove useful in exploring genes that
are important in retroviral activation and ALS, which may
help discover new drug targets.
The next paper by Shah et al. [10] presented BayesMe-
tab, a bioinformatics method for the treatment of miss-
ing values in metabolomic studies using a Bayesian
modeling approach. Missing values (MVs) are pervasive,
yet the treatment of MVs can have a substantial impact
on downstream statistical analyses of metabolomics data.
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The MVs problem in metabolomics can arise because
the metabolite is not biologically present in the sample,
or is present in the sample but at a concentration below
the lower limit of detection (LOD), or is present in the
sample but undetected due to technical issues related to
sample pre-processing steps. The former is considered
missing not at random (MNAR) while the latter is an ex-
ample of missing at random (MAR). Typically, such
MVs are substituted by a minimum value, which may
lead to severely biased results in downstream analyses.
Here, the authors developed a Bayesian model that
systematically accounts for missing values based on a
Markov chain Monte Carlo (MCMC) algorithm that in-
corporates data augmentation by allowing MVs to be
due to either truncation below the LOD or other tech-
nical reasons unrelated to its abundance. Their simula-
tion results indicate that the proposed Bayesian method
outperformed other imputation algorithms when there is
a mixture of missingness due to MAR and MNAR. Fur-
ther, their approach was competitive with other methods
tailored specifically to MNAR in situations where miss-
ing data were completely MNAR. Their method was also
tested on a real metabolomics dataset from a mouse
myocardial infarction, and it revealed several statistically
significant metabolites not previously identified but with
direct biological relevance to the study. In summary,
these findings demonstrate that the proposed Bayesian
method has improved performance in imputing the
missing values and performing statistical inference com-
pared to other current methods when missing values are
due to a mixture of MNAR and MAR.
The next paper by Gadepalli et al. [11] described
BISR-RNAseq, an efficient and scalable RNA-Seq ana-
lysis workflow with interactive report generation. The
BISR-RNAseq workflow implements several open-source
software tools that can be run on a high performance
computing environment. The workflow allows for the
analysis (alignment, quality control, gene-wise counts
generation) of raw RNA-Seq data and seamless integra-
tion of quality analysis and differential expression results
into a configurable R shiny web application. Scripts are
set up to run in a high performance computing (HPC)
environment that utilizes portable batch system (PBS)
for job scheduling and could be easily modified for other
schedulers such as slurm. To further evaluate the effect-
iveness of the workflow, the authors applied the pipeline
to a few publicly available RNA-seq datasets downloaded
from Gene Expression Omnibus (GEO) and demon-
strated how the workflow could facilitate users to per-
form RNA-seq data analysis in a user-friendly interface.
The next paper by Church et al. [12] tried to under-
stand gene expression heterogeneity by investigating
skewness in large patient cohorts. Skewness is a statis-
tical measure that captures the degree of asymmetry in
the distribution of any dataset. This study applied a new
metric based on skewness to identify regulators or genes
that have outlier expression in large patient cohorts. The
authors investigated whether specific patterns of skewed
expression were related to the enrichment of biological
pathways or genomic properties such as DNA methylation
status. The authors used several publicly available datasets
that were generated using both RNA-seq and microarray
technology platforms. When comparing the shift in ex-
pression skewness between cancer and control datasets,
they observed an enrichment of pathways related to im-
mune function that reflect increases towards positive
skewness in the cancer relative to control datasets. Signifi-
cant correlation was also detected between expression
skewness and differential DNA methylation occurring in
the promotor regions for four TCGA cancer cohorts. In
summary, these results indicate that expression skewness
can reveal new insights into transcription based on outlier
and asymmetrical behavior in large patient cohorts.
In the last paper, Eicher et al. [13] performed a compari-
son of analysis methods with the case study of the DREAM
Proteogenomics Challenge data. Proteomic measurements
provide insights into gene expression regulations and
mechanisms underlying altered phenotypes, while the inte-
gration of proteome and transcriptome data can validate
gene signatures associated with a phenotype. However,
proteomic data is not as abundant as genomic data, and it
is thus beneficial to use genomic features to predict protein
abundances when matching proteomic samples or mea-
surements within samples are lacking. In the current study,
the authors evaluated and compared three data-driven
models for prediction of proteomic data from mRNA in
breast and ovarian cancers using the 2017 DREAM Proteo-
genomics Challenge datasets. Their results showed that
Bayesian network and random forest approaches could pre-
dict protein abundance levels with median ground truth
(predicted correlation values were between 0.29 and 0.55).
Logic-based predictors were not as accurate overall,
but performed well for a subset of proteins across
multiple cross-validations. In summary, they bench-
marked several machine learning approaches for pre-
dicting proteomic data from gene expression data,
and discussed the challenges and potential solutions
in state-of-the-art proteogenomic analyses.
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